1. Home
  2. AVTR vs HALO Comparison

AVTR vs HALO Comparison

Compare AVTR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avantor Inc.

AVTR

Avantor Inc.

HOLD

Current Price

$10.40

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$76.19

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVTR
HALO
Founded
1904
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
8.1B
IPO Year
2019
2001

Fundamental Metrics

Financial Performance
Metric
AVTR
HALO
Price
$10.40
$76.19
Analyst Decision
Hold
Buy
Analyst Count
13
11
Target Price
$12.42
$78.64
AVG Volume (30 Days)
7.8M
1.8M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
1.22
Revenue
$6,552,200,000.00
$151,862,000.00
Revenue This Year
$1.05
$28.24
Revenue Next Year
$1.86
$12.56
P/E Ratio
$175.17
$64.48
Revenue Growth
N/A
N/A
52 Week Low
$7.27
$55.64
52 Week High
$15.93
$82.26

Technical Indicators

Market Signals
Indicator
AVTR
HALO
Relative Strength Index (RSI) 61.29 55.48
Support Level $9.02 $67.12
Resistance Level $11.35 $82.22
Average True Range (ATR) 0.42 2.44
MACD -0.00 0.25
Stochastic Oscillator 84.16 56.50

Price Performance

Historical Comparison
AVTR
HALO

About AVTR Avantor Inc.

Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: